Shuttle Pharmaceuticals is a biotechnology and pharmaceutical company headquartered in Rockville, MD, United States. Founded in 2012, the company recently received a significant $4.00M post-IPO debt investment on 12 January 2023. This injection of capital signifies strong investor confidence in Shuttle Pharma’s potential for growth and innovation within the biotech and pharmaceutical industries. The company’s focus on cutting-edge research and development positions it as an attractive opportunity for venture capital firms seeking high-potential investment prospects. As the demand for advanced pharmaceutical solutions continues to rise, Shuttle Pharma’s strategic positioning stands to yield substantial returns for investors in the coming years.
Shuttle Pharmaceuticals, Inc.
Founded 2012
Rockville, United States
8 employees
Post Ipo Debt
Total: $4.91M
Biotechnology, Health and Wellness +1
Rockville, United States
8 employees
Post Ipo Debt
Total: $4.91M
Biotechnology, Health and Wellness +1
General Information
Get notified when Shuttle Pharmaceuticals, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Shuttle Pharmaceuticals, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Shuttle Pharmaceuticals, Inc.
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Debt | •••••• | - | 12 Jan 2023 | |
| Seed Round | •••••• | - | 30 Jan 2019 |
Shuttle Pharmaceuticals, Inc. Alternatives & Competitors
Shuttle Pharmaceuticals, Inc. vs
Cvergenx
United States
An innovative leader in cancer molecular diagnostics, delivering personalized radiation therapy to e...
Seed
2 employees
Biotechnology, Health Care
Shuttle Pharmaceuticals, Inc. vs
Lutris Pharma
Israel
Improving Anti-Cancer Therapy by Reducing Dose-Limiting Side Effects
Grant
4 employees
Biotechnology, Health Care
Shuttle Pharmaceuticals, Inc. vs
FAQ About Shuttle Pharmaceuticals, Inc.
Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company developing novel therapies and diagnostics to improve the outcomes for cancer patients treated with radiation therapy. Our technology sensitizes growing cancer cells, rendering them susceptible to the effects of radiation therapy, ac...
Shuttle Pharmaceuticals, Inc. was founded in 2012.
Shuttle Pharmaceuticals, Inc. is headquartered in Rockville, United States.
Shuttle Pharmaceuticals, Inc. operates in the following industries: Biotechnology, Health and Wellness, Pharmaceutical.
Shuttle Pharmaceuticals, Inc. has approximately 8 employees.
Shuttle Pharmaceuticals, Inc. has completed 2 funding rounds, raising a total of $4.91M. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to Shuttle Pharmaceuticals, Inc. include Cvergenx, Lutris Pharma, Astera Cancer Care, Smart Immune, Andarix Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Shuttle Pharmaceuticals, Inc. and Cvergenx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Shuttle Pharmaceuticals, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.